TBO.com > News > Latest News Reports
- Moffitt Among Quarterfinalists For Lott Award
- Two Women Thrown From Boat When It Hits I-75 Bridge
- Judge Imposes Stay On Lethal Injections
- Poll: More Coastal Residents Would Not Evacuate For Hurricane
- Robbers In Ninja Garb Strike Hampton Inn
- Deputy Is Accused Of Domestic Battery
- 2 Men Burst Into Home, Steal More Than $7,000
- Temple Terrace Man Wounded In Shooting
- Polk Deputies Charge 17 Men After Weekend Cockfight
- Baby Dropped Off At Fire Station
- Jury Awards $21.1 Million In Wrongful Birth Case
- Deputies Investigate Bank Robbery
- Grandpa Robbed; Grandson Charged
- Composite Sketch Of Armed Carjacker Released
- Progress Village Homicide Victim ID’d
The Moffitt research center at the University of South Florida is conducting a study of HPV in males. Crystal L. Lauderdale/Tampa Tribune
Video: HPV Vaccine In The Spotlight | Study Published In JAMA
By SHERRI ACKERMAN
The Tampa Tribune
TAMPA - HPV is in the national spotlight, with a new vaccine for girls touted to prevent them from developing cancer as a result of the sexually transmitted disease.
But inside a lab at the H. Lee Moffitt Cancer Center & Research Institute, scientists are uncovering other links to HPV that pose health threats for men as well.
Men infected by certain strains of HPV run the risk of developing penile and anal cancers, said Anna Giuliano, a Tampa scientist who has studied the virus for nearly two decades.
Giuliano is leading three studies concerning HPV: a vaccine trial for men, which started two years ago; another that focuses on the rate of infection — which is showing males have high infection rate — and a third that looks at transmission in heterosexual couples.
Advertisement
